10x Genomics, Inc. — Director's Dealing 2021

Feb 12, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-12-31

Reporting Person: ROBERTS BRYAN E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-22	Class A Common Stock	G	46500	$0.00	Disposed	168791	Direct
2020-12-22	Class A Common Stock	G	46500	$0.00	Acquired	46500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	2037825	Indirect

Footnotes

F1: These shares of Class A Common Stock were gifted to a trust for the benefit of the Reporting Person's children.

F2: These shares of Class A Common Stock were previously reported as directly beneficially owned but were contributed to a trust for the benefit of the Reporting Person's children on December 22, 2020.

F3: Consists of 1,889,497 shares of Class A Common Stock held by Venrock Associates VI, L.P. and 148,328 shares of Class A Common Stock held by Venrock Partners VI, L.P.